| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |